[Dose-effect studies with bismuth salts for the elimination of Campylobacter pylori].
Menge
H
H
Akademisches Lehrkrankenhaus Remscheid-Lennep, Medizinische Klinik II.
Hofmann
J
J
Gregor
M
M
D001729:Bismuth; D002169:Campylobacter Infections / Q000188:drug therapy*; D002908:Chronic Disease; D004305:Dose-Response Relationship, Drug; D005756:Gastritis / Q000188:drug therapy*; D006801:Humans; D009942:Organometallic Compounds / Q000008:administration & dosage / Q000627:therapeutic use*; D012459:Salicylates / Q000008:administration & dosage / Q000627:therapeutic use*
D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; C002791:bismuth tripotassium dicitrate; D001729:Bismuth
Dosis-Wirkungs-Studien mit Wismutsalzen zur Elimination von Campylobacter pylori.